Related Experiment Video
Updated: Jan 15, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Autonomic dysfunction in patients with episodic cluster headache during remission period
Alba López-Bravo1,2,3, Elena Bellosta Diago4,5, Marisa de la Rica Escuín4,5
1Neurology Department, Reina Sofía Hospital, Tudela, Navarra, Spain. alba.lopez@unavarra.es.
Cluster headache (CH) patients show reduced heart rate variability (HRV) and elevated norepinephrine levels during remission, indicating autonomic nervous system (ANS) imbalance. This suggests potential autonomic dysfunction even between attacks.
Area of Science:
- Neurology
- Autonomic Neuroscience
- Cardiovascular Physiology
Background:
- The hypothalamus plays a role in cluster headache (CH) pathophysiology and autonomic control.
- Cranial autonomic symptoms are characteristic during CH attacks, but other autonomic manifestations may occur.
- This study investigates the autonomic nervous system (ANS) in CH patients during remission.
Purpose of the Study:
- To explore autonomic nervous system function in patients with cluster headache during their remission period.
- To identify potential autonomic imbalances in CH patients outside of active attacks.
Main Methods:
- A cross-sectional study involving 30 CH patients and 30 age- and sex-matched controls.
- Analysis of time- and frequency-domain heart rate variability (HRV) parameters.
- Assessment of sympathetic nervous system activity via plasma norepinephrine (NE) levels and active orthostatic tests.
Main Results:
- CH patients exhibited significantly lower HRV parameters, including pNN50 and SDNN, compared to controls.
- Mean heart rate (HR) was significantly higher in CH patients.
- Plasma norepinephrine (NE) levels were significantly elevated in both supine and standing positions in CH patients.
Conclusions:
- A significant decrease in HRV and elevated plasma NE levels suggest an autonomic nervous system imbalance in CH patients during remission.
- These findings indicate persistent autonomic dysfunction in CH, even between symptomatic attacks.
Related Concept Videos
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Drugs Acting on Autonomic Ganglia: Blockers
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
Autonomic Nervous System
The ANS comprises two main divisions: the sympathetic and parasympathetic divisions. These divisions function antagonistically to maintain a dynamic...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

